Study of drug «mamoclam» for treatment of benign breast disease

Voprosy Onkologii

Volumn 51, Issue 2, 2005, Pages 236-241

  Bespalov, V G ^a   Barash, N Yu ^a   Ivanovo, O A ^a   Semenov, I I ^a   Alexandrov, V A ^a   Semiglazov, V F ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROPHYLL; IODINE; MAMOCLAM; NEW DRUG; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ADULT; ALGA; ALGOMENORRHEA; ARTICLE; BENIGN TUMOR; BREAST CYST; BREAST DISEASE; CLINICAL EXAMINATION; CLINICAL TRIAL; DYSMENORRHEA; ECHOMAMMOGRAPHY; FEMALE; HUMAN; MAMMOGRAPHY; MASTALGIA; MENSTRUATION DISORDER; PALPATION; PREMENSTRUAL SYNDROME; TABLET FORMULATION; TREATMENT OUTCOME; BREAST TUMOR; DRUG ADMINISTRATION; FIBROADENOMA;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHLOROPHYLL; DRUG ADMINISTRATION SCHEDULE; FATTY ACIDS, OMEGA-3; FEMALE; FIBROADENOMA; HUMANS; IODINE; TREATMENT OUTCOME;

EID: 20444380986     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Abayasekara D.R., Wathes D.C. Effects of altering dietary fatty acid composition on prostaglandin synthesis and fertility // Prostaglandins Leukot. Essent. Fatty Acids. - 1999. - Vol. 61. - P. 275-287.
2. Allred D.C., Mohsin S.K., Fuqua S.A.W. Histological and biological evolution of human premalignant breast disease // Endocrin. Relat. Cancer. - 2001. - Vol. 8. - P. 47-61.
3. Armstrong K., Eisen A., Weber B. Assessing the risk of breast cancer // N. Engl. J. Med. - 2000. - Vol. 342. - P. 564-571.
4. Cann S.A., van Netten J.P., van Netten C. Hypothesis: iodine, selenium and the development of breast cancer // Cancer Causes Control. - 2000. - Vol. 11. - P. 121-127.
5. El-Wakeel H., Umpleby H.C. Systematic review of fibroadenoma as a risk factor for breast cancer // Breast. - 2003. - Vol. 12. - P. 302-307.
6. Ghent W.R., Eskin B.A., Low D.A., Hill L.P. Iodine replacement in fibrocystic disease of the breast // Can. J. Surg. - 1993. - Vol. 36. - P. 453-460.
7. Hasegawa R., Hirose M., Kato T. et al. Inhibitory effect of chlorophyllin on PhlP-induced mammary carcinogenesis in female F344 rats // Carcinogenesis. - 1995. - Vol. 16. - P. 2243-2246.
8. IARC Working Group on the Evaluation of Cancer-Preventive Strategies. Breast Cancer Screening. - IARC Handbooks of Cancer Prevention. - Vol. 7. - France: International Agency for Research on Cancer, 2002. - 229 p.
9. International Statistical Classification of Diseases and Related Health Problems. Tenth Revision. Volume 1. - Geneva: World Health Organization, 1992.
10. Larsson S.C., Kumlin M., Ingelman-Sundberg M., Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms // Amer. J. Clin. Nutr. - 2004. - Vol. 79. - P. 935-945.
11. Li D. Omega-3 fatty acids and non-communicable diseases // Chin. Med. J. - 2003. - Vol. 116. - P. 453-458.
12. Marchant D.J. Benign breast disease // Obstet. Gynecol. Clin. North. Amer. - 2002. - Vol. 29. - P. 1-20.
13. Schnitt S.J. Benign breast disease and breast cancer risk: morphology and beyond // Amer. J. Surg. Pathol. - 2003. - Vol. 27. - P. 836-841.
14. Smyth P.P. The thyroid, iodine and breast cancer // Breast Cancer Res. - 2003. - Vol. 5. - P. 235-238.
15. Vanderpump M.P., Tunbridge W.M. Epidemiology and prevention of clinical and subclinical hypothyroidism // Thyroid. - 2002. - Vol. 12. - P. 839-847.
16. Wang J., Costantino J.P., Tan-Chiu E. et al. Lower-category benign breast disease and the risk of invasive breast cancer // J. Natl. Cancer Inst. - 2004. - Vol. 96. - P. 616-620.